Ultrasound-Guided Cystocentesis for Therapeutic Drainage in Dogs and Cats

By Dr. Zubair Khalid, DVM, MS, PhD ·

Ultrasound-Guided Cystocentesis for Therapeutic Drainage in Dogs and Cats

Key Takeaways

  • Therapeutic cystocentesis is indicated for relieving urinary bladder distension when urethral catheterization is contraindicated, has failed, or is undesirable, particularly in cases of lower urinary tract obstruction, neurogenic bladder, or detrusor atony.
  • The ventral or ventrolateral bladder wall, avoiding the apex and trigone, is the preferred puncture site due to its relative avascularity, minimizing risks of hemorrhage and pain.
  • Ultrasound guidance is critical for therapeutic drainage, enabling real-time visualization of the needle tip within the bladder lumen and confirming bladder distension for safe access.
  • Key complications include urine leakage into the peritoneal cavity (uroabdomen), hemorrhage, bladder rupture, and inadvertent organ puncture, necessitating careful patient selection and meticulous technique.
  • Post-drainage monitoring should include serial ultrasound to assess bladder re-accumulation, urine output measurement, and vigilant observation for signs of peritonitis or hemorrhage.
  • Needle selection ranges from 20-22 gauge, 3.75-7.5 cm, with over-the-needle catheters recommended for repeated or prolonged drainage to ensure secure access.

Ultrasound-guided cystocentesis is a core interventional skill in small animal practice, expected of new graduates by a substantial majority of practitioners, faculty, and recent graduates surveyed across accredited veterinary colleges in the United States and Caribbean. The procedure serves two distinct purposes: diagnostic sample acquisition and therapeutic drainage. This article addresses the therapeutic application, where the urinary bladder is decompressed to relieve obstruction, manage neurogenic or atonic bladder states, or facilitate medical management of conditions that impair normal voiding. The intended reader is the practicing veterinarian who has mastered basic ultrasound-guided needle placement and now requires a structured framework for safe, effective, and repeatable therapeutic bladder drainage.

The clinical question this article answers is practical: when is therapeutic cystocentesis appropriate, how should the procedure be planned and executed to minimize complications, and what aftercare distinguishes a successful intervention from a failed one? Diagnostic urine collection, cystoscopy, and surgical cystotomy are outside the scope of this discussion. The evidence base for therapeutic drainage is thinner than that for diagnostic cystocentesis, and much of what follows draws on established principles of ultrasound-guided intervention, urinary tract physiology, and complication management instead of on controlled trials. Where the literature is limited, this is stated directly.

At a Glance

ParameterRecommendation or Fact
Primary indicationRelief of urinary bladder distension when urethral catheterization is contraindicated, has failed, or is undesirable
Patient selectionConfirmed or strongly suspected lower urinary tract obstruction, neurogenic bladder, or detrusor atony with ultrasound-confirmed bladder distension
ContraindicationsKnown bladder neoplasia at the puncture site, severe coagulopathy, recent bladder surgery, inability to safely restrain or position the patient
Needle selection20 to 22 gauge, 3.75 to 7.5 cm, with stylet, over-the-needle catheter for repeated or prolonged drainage
Target siteVentral or ventrolateral bladder wall, avoiding the apex, trigone, and visible vessels
Maximum drainageDrain to near-empty but do not aspirate the bladder wall into the needle, leave a small residual volume
Key complicationUrine leakage into the peritoneal cavity, uroabdomen, hemorrhage, bladder rupture, or inadvertent organ puncture
Post-drainage monitoringSerial ultrasound to assess re-accumulation, urine output measurement, and monitoring for peritonitis or hemorrhage

Physiology of Bladder Distension and Drainage

The urinary bladder is a distensible muscular organ whose wall thickness varies inversely with luminal volume. In a distended bladder, the wall becomes thin and the serosal surface is closely apposed to the abdominal wall, which facilitates safe needle access. In a contracted or partially filled bladder, the wall is thick, mobile, and easily pushed away by the needle tip, increasing the risk of a through-and-through puncture or a serosal tear. This mechanical relationship is the central reason ultrasound guidance is preferred over blind or palpation-guided cystocentesis for therapeutic drainage: real-time imaging confirms that the needle tip remains within the lumen throughout the drainage period.

The bladder receives its blood supply from the cranial and caudal vesicular arteries, branches of the internal iliac and umbilical arteries. These vessels run along the lateral bladder surfaces and are not visible on routine B-mode ultrasound in most patients. The ventral bladder wall is relatively avascular, which is why it is the preferred puncture site. The trigone, by contrast, is densely innervated and vascular, and puncture there risks hemorrhage and pain. The bladder apex is thin-walled and mobile, and puncture at this site may tear during decompression as the wall collapses around the needle.

Drainage of a distended bladder produces an immediate reduction in intravesical pressure, which improves perfusion of the bladder wall and reduces the stimulus for reflex detrusor contraction. In obstructive disease, decompression also relieves pressure on the ureteral orifices, allowing urine to flow from the kidneys into the bladder instead of backing up into the renal pelves. This is clinically relevant in complete urethral obstruction, where prolonged high intravesical pressure contributes to post-obstructive diuresis and acute kidney injury. Therapeutic drainage therefore serves both a mechanical and a renal-protective role.

Evidence Base and Procedural Context

Ultrasound-guided cystocentesis is a well-established technique in veterinary medicine, and its diagnostic application is supported by studies across species. In captive nondomestic felids, ultrasound-guided cystocentesis performed during routine health checks under general anesthesia yielded urine samples suitable for sediment examination, specific gravity measurement, and protein-to-creatinine ratio determination, with proteinuria or borderline proteinuria identified in nearly half of the animals examined. This demonstrates that the technique is reliable for sample acquisition even in challenging patients, and it supports the broader principle that ultrasound-guided bladder access is a dependable intervention when performed with appropriate imaging.

The diagnostic literature also informs therapeutic practice in an indirect way. Studies of urinary tract infection in dogs and cats have relied on ultrasound-guided cystocentesis to obtain uncontaminated samples for culture and susceptibility testing, confirming that the procedure can be performed repeatedly and safely in clinical populations. In one institutional study of uropathogens in companion animals, samples collected by ultrasound-guided cystocentesis from 31 dogs and 9 cats yielded clinically relevant bacterial isolates, with Escherichia coli the most common pathogen. The ability to obtain such samples without urethral catheterization is a key advantage of the technique, and it extends to therapeutic drainage, where repeated bladder access may be required over days or weeks.

The expectation that new veterinary graduates can perform cystocentesis competently is well documented. A cross-sectional survey of stakeholders, including practitioners, faculty, recent graduates, and students, found that 93% to 97% of respondents expected new graduates to adequately perform cystocentesis on their first day of practice. This expectation places a responsibility on educators and supervisors to ensure that graduates are also able to perform the procedure but also understand its indications, limitations, and complications, particularly in the therapeutic context where the stakes are higher than in routine diagnostic collection.

Indications for Therapeutic Drainage

Therapeutic cystocentesis is indicated when the bladder is distended and urine cannot be evacuated by normal voiding or urethral catheterization. The most common scenario is urethral obstruction, typically from urolithiasis, urethral plugs, or neoplasia, where catheterization may be impossible or may risk further trauma to an already compromised urethra. In these cases, therapeutic drainage provides temporary relief while definitive management, such as surgery or medical dissolution, is planned. Drainage also reduces the pressure gradient across the obstructed segment, which may facilitate subsequent catheter passage.

Neurogenic bladder and detrusor atony are additional indications. Patients with spinal cord injury, intervertebral disc disease, or sacral nerve dysfunction may be unable to void voluntarily, and repeated catheterization carries a risk of urinary tract infection and urethral trauma. Therapeutic cystocentesis offers an alternative for decompression, particularly in patients where catheterization is technically difficult or where the owner is managing the patient at home between hospital visits. The technique is also used in the management of patients with bladder rupture or leakage, where drainage of the bladder reduces ongoing urine extravasation into the peritoneal cavity while surgical repair is arranged.

The decision to drain therapeutically instead of to catheterize depends on patient factors, available equipment, and the underlying disease. In a patient with a urethral obstruction that can be relieved by catheterization, catheterization is generally preferred because it provides a route for ongoing drainage and allows monitoring of urine output. Therapeutic cystocentesis is reserved for cases where catheterization has failed, is contraindicated, or is not immediately available. This decision framework is pragmatic and reflects the reality of clinical practice, where the availability of urinary catheters, sedation, and skilled personnel varies considerably between practices and settings.

Patient Assessment and Case Selection

Therapeutic drainage is indicated when bladder distension causes pain, threatens mucosal integrity, or impairs cardiovascular or respiratory function. Common scenarios include urethral obstruction with failed or deferred catheterization, severe hematuria with clot retention, and decompression before imaging or surgery in patients where urethral catheterization is contraindicated.

Before proceeding, confirm that the distension is urinary and not another abdominal mass. Ultrasonography should identify the bladder as a thin-walled, anechoic, fluid-filled structure in the caudal abdomen. If the wall is irregular, thickened, or associated with a mass, reconsider the diagnosis. A distended bladder with a palpable turgid mass in a male cat with dysuria supports obstruction, but ultrasound may reveal a bladder that is small and empty while a urachal remnant or paraprostatic cyst accounts for the palpable structure.

Assess the patient for coagulopathy. A history of anticoagulant rodenticide exposure, thrombocytopenia, or hepatic failure increases bleeding risk. Ultrasonography can identify a distended bladder with echogenic contents consistent with blood clots, but it cannot exclude a bleeding diathesis. If coagulopathy is suspected and drainage is not urgent, obtain a platelet count and coagulation profile first. When drainage is urgent and coagulopathy cannot be excluded, use the smallest gauge needle that will drain the bladder and apply sustained post-procedural pressure.

Patient positioning matters. Dorsal recumbency with the transducer placed caudal to the umbilicus is standard, but lateral recumbency may be preferable in dyspnoeic patients or those with severe abdominal distension. In lateral recumbency, the bladder falls toward the dependent side, and the needle path is adjusted accordingly. For obese patients, a dorsal approach through the body wall may require a longer needle, and the bladder may sit more cranially than expected.

Equipment Selection and Preparation

Use a curvilinear or microconvex transducer for most dogs and cats. Frequencies of 5 to 8 MHz suit medium and large dogs, while 8 to 12 MHz provides better near-field resolution in cats and small dogs. A standoff pad is rarely needed because the bladder lies within a few centimetres of the skin surface in most patients.

Needle selection depends on patient size and the volume to be drained. A 22 gauge, 2.5 to 4 cm needle suits most cats and small dogs. Larger dogs may require a 20 gauge, 5 to 7.5 cm needle. Spinal needles with a stylet reduce the risk of coring a plug of tissue and are preferred when the bladder wall is thick or the patient is obese. Over-the-needle catheters, such as a 20 or 22 gauge intravenous catheter, allow secure drainage when a large volume must be removed or when the bladder may refill during a prolonged procedure.

A three-way stopcock and extension set attached to the needle hub permit controlled drainage into a collection bag or syringe without repeated needle manipulation. This arrangement also allows the operator to measure drained volume accurately. Sterile ultrasound gel is mandatory. Non-sterile gel should never contact the needle entry site.

The procedure should be performed with aseptic technique. Clip the hair over the caudal ventral abdomen, scrub the skin with chlorhexidine or povidone-iodine, and apply sterile gel to the transducer or use a sterile probe cover. The operator should wear sterile gloves. The assistant holds the transducer or the operator holds it in the non-dominant hand while the dominant hand advances the needle.

Ultrasound-Guided Technique

Begin with a systematic survey of the urinary tract. Identify both kidneys, assess renal pelvis dilation, and trace the ureters when visible. Evaluate the bladder wall thickness, luminal contents, and the region of the trigone. In a male dog, examine the prostate. In any patient with suspected obstruction, look for urethral calculi or a distended proximal urethra.

Select the needle entry site where the bladder wall is closest to the skin and where the needle path avoids the spleen, intestines, and body wall vasculature. The ideal target is the cranioventral or ventrolateral bladder wall, away from the trigone and the ureteral openings. The needle should enter the bladder at an oblique angle, approximately 30 to 45 degrees to the bladder wall, instead of perpendicular. An oblique path creates a longer tunnel through the wall, which seals more effectively when the needle is withdrawn.

Two ultrasound-guided approaches are available. In the freehand technique, the operator holds the transducer in one hand and the needle in the other, aligning the needle with the ultrasound beam. This method requires practice but allows continuous visualization of the needle tip. In the guide technique, a needle guide bracket attached to the transducer directs the needle along a fixed path displayed on the screen. The guide technique is easier for novices but limits the operator's ability to redirect the needle.

Advance the needle in short, controlled increments while watching the screen. The needle tip appears as a bright echogenic dot. If the tip is not visible, gently rock the transducer or move the needle slightly to identify its position. Never advance the needle blindly. When the tip contacts the bladder wall, a subtle indentation of the wall may be visible before the needle penetrates. Apply steady, gentle pressure to advance through the wall. A sudden loss of resistance and the appearance of urine in the extension set confirm entry into the lumen.

Drain the bladder slowly. Rapid decompression can cause hypotension, particularly in obstructed patients with post-obstructive diuresis. Remove no more than 75 to 80 percent of the estimated bladder volume in a single pass. If the bladder collapses around the needle tip, the tip may exit the lumen. Watch the screen continuously and withdraw the needle slightly if the tip appears to be outside the bladder. When drainage is complete, withdraw the needle smoothly and apply firm manual pressure over the puncture site for two to three minutes.

Monitoring and Complications

Monitor the patient throughout the procedure for bradycardia, hypotension, or signs of pain. Vagal stimulation from bladder distension or rapid decompression can cause bradycardia. If the heart rate drops, pause drainage and allow the patient to stabilize. Hypotension after drainage may reflect rapid volume shifts or pre-existing dehydration.

Hemorrhage is the most significant complication. Mild hematuria after cystocentesis is common and usually self-limiting. Persistent hematuria, a falling packed cell volume, or abdominal effusion after the procedure suggests significant bleeding. Ultrasonography can identify free fluid in the abdomen, and a fluid sample with a packed cell volume above 5 percent supports hemorrhage. Apply additional manual pressure and consider a pressure bandage if the puncture site is accessible.

Urine leakage into the abdomen is a recognized complication. The oblique needle path reduces this risk, but leakage can still occur if the bladder is over-distended, if the needle is withdrawn while the bladder is still under pressure, or if the patient moves during the procedure. Small volumes of sterile urine in the peritoneal cavity are usually resorbed without clinical consequence. Larger volumes, or urine with bacterial contamination, can cause peritonitis. If the patient develops abdominal pain, fever, or progressive abdominal distension after drainage, evaluate for peritonitis.

Bladder rupture is rare but possible, particularly in patients with a thin or compromised bladder wall. The risk increases when the bladder is drained to near-empty and the needle tip is not visualized. If rupture is suspected, confirm with ultrasonography, which may show a decompressed bladder with free abdominal fluid. Surgical repair is indicated for significant rupture.

The following table summarizes the key monitoring parameters and their clinical significance during and after therapeutic drainage.

ParameterTimingWhat it detectsAction threshold
Heart rate and rhythmContinuous during drainageVagal response, pain, hypotensionPause drainage if bradycardia develops
Mucous membrane color and capillary refill timeBefore, during, and afterHypovolemia, hemorrhageProlonged refill or pallor warrants fluid therapy and reassessment
Packed cell volume and total solidsBaseline and 2 to 4 hours afterHemorrhageFall of more than 5 percent from baseline warrants investigation
Abdominal ultrasoundImmediately after and 12 to 24 hours laterFree fluid, bladder wall defect, residual clotNew or increasing free fluid warrants sampling and cytology
Urine output6 to 12 hours after drainagePost-obstructive diuresis, renal functionInadequate output in a previously obstructed patient warrants reassessment
Body temperature12 to 24 hours afterPeritonitis, systemic inflammationFever with abdominal pain warrants diagnostic imaging and sampling

Documentation and Aftercare

Record the indication for drainage, the volume removed, the appearance of the urine, and any complications. Note the ultrasound findings, including bladder wall thickness, luminal contents, and the presence of free abdominal fluid. Describe the needle gauge, approach, and number of attempts. If urine was submitted for culture, cytology, or other testing, document the sample handling and transport conditions.

Aftercare depends on the underlying condition. For a patient with urethral obstruction, therapeutic drainage is a temporising measure, and definitive management of the obstruction must follow. For a patient with hematuria and clot retention, drainage may be repeated if the bladder refills with clots. In all cases, reassess the patient within 12 to 24 hours to confirm that the bladder is refilling normally and that no complications have developed.

The evidence base for therapeutic cystocentesis in companion animals is limited. Most published work addresses diagnostic cystocentesis, including its use in feline idiopathic cystitis research and in the evaluation of urinary biomarkers in dogs and non-domestic felids. The procedural principles described here are consistent with standard veterinary imaging practice as outlined in professional resources such as the MSD Veterinary Manual and the American College of Veterinary Radiology resources, but specific complication rates for therapeutic drainage are not well established. Practitioners should exercise clinical judgment and adapt the technique to the individual patient.

Complications and Failure Modes

Therapeutic drainage carries a small but real risk of complications. Hematuria is the most frequently observed adverse event, and it is usually transient and self-limiting. Clinically significant hemorrhage is rare when the bladder is adequately distended and the needle path avoids the dorsal vessels. Bladder rupture can occur if the bladder is over-distended, if the patient moves suddenly, or if the needle tip is advanced against a collapsing bladder wall. Urine leakage into the peritoneal cavity is a theoretical concern, but clinically important peritonitis is uncommon when the urine is sterile. Iatrogenic bowel penetration is possible when the bladder is small or when the patient has concurrent gastrointestinal distension.

Early detection of complications relies on observation during and immediately after the procedure. The ultrasound image should be monitored continuously while the needle is in place. A sudden loss of bladder volume without corresponding flow through the collection line suggests leakage around the needle or into the peritoneal cavity. Post-procedural ultrasound should confirm that the bladder wall is intact and that free fluid has not accumulated in the abdomen. The patient should be observed for stranguria, persistent hematuria beyond 24 hours, or signs of abdominal pain. Serial hematocrit measurement is indicated if hemorrhage is suspected.

ObservationLikely causeDiscriminating check
Blood flows through collection lineNeedle tip in bladder wall or peri-vesicular vesselsWithdraw needle slightly, confirm tip is within the lumen, reassess color of flow
Bladder volume decreases slowly or not at allNeedle tip against mucosa, kinked line, or clot obstructing the catheterRotate needle, flush line with sterile saline, reposition tip toward the dependent portion
Free fluid appears in the abdomen during drainageBladder wall puncture with leakage, or pre-existing effusionCompare pre- and post-procedural images, assess volume and echogenicity of the fluid
Patient vocalises or moves suddenlyNeedle contacting the body wall, bladder serosa, or adjacent visceraStop drainage, reassess needle position, consider additional sedation or analgesia
No urine obtained despite apparent bladder distensionBladder is not the anechoic structure being imaged, or the bladder is decompressedIdentify the bladder neck and ureteral entry points, scan for a second fluid-filled structure

Common Errors and Corrective Action

Less experienced clinicians most often fail to confirm that the bladder is the structure being targeted. A fluid-filled loop of bowel, a cystic ovarian remnant, or a distended urethra can mimic the bladder on B-mode imaging. The bladder is identified by its location caudal to the small intestine, its thin uniform wall, and the presence of the ureteral jets when color Doppler is available. The needle should be visualized along its full length before drainage begins.

A second common error is attempting drainage when the bladder is insufficiently distended. The bladder wall folds on itself, and the needle tip can pass through both walls without entering the lumen. The corrective action is to defer the procedure, administer intravenous fluids, and re-scan after 30 to 60 minutes. In patients where diuresis is undesirable, a urinary catheter can be used to instil sterile saline to achieve distension, although this adds time and instrumentation.

Advancing the needle too far is another frequent mistake. The needle should be inserted at a steep angle so that the tip is visible as it enters the bladder, and advancement should stop immediately after the tip crosses the dorsal wall. The stylet of an over-the-needle catheter should be withdrawn as soon as the tip is within the lumen, and the catheter should be advanced off the stylet instead of pushing the entire assembly deeper. Clinicians who use a syringe-mounted needle should aspirate gently and stop as soon as urine flows.

Limitations of the Evidence and Divergent Expert Opinion

The evidence base for therapeutic cystocentesis is drawn largely from studies of diagnostic collection. Stakeholder surveys indicate that new graduates are expected to perform cystocentesis competently on their first day of practice, which suggests that the procedure is considered a core skill, but the same surveys do not address therapeutic drainage specifically. Studies of urine collected by ultrasound-guided cystocentesis in cats with idiopathic cystitis have shown no viable bacterial communities, which supports the safety of the approach in this population, but these studies were not designed to assess drainage outcomes. Reference intervals for urinary analytes have been established using cystocentesis samples in dogs, and these provide indirect evidence that the procedure is well tolerated, but they do not quantify complication rates.

Expert opinion differs on several points. Some clinicians advocate routine use of an over-the-needle catheter for all therapeutic drainage, while others prefer a butterfly needle for speed and simplicity. There is no published consensus on the maximum volume that should be removed in a single session. Most experts recommend leaving some urine in the bladder to maintain wall apposition, but the exact residual volume is not standardized. The role of prophylactic antimicrobials after therapeutic drainage is also debated. The available evidence on antimicrobial resistance in uropathogens from companion animals supports the general principle of avoiding unnecessary antimicrobial use, but it does not resolve the question of post-drainage prophylaxis.

Referral, Consultation, and Reporting

Referral to a specialist is warranted when the bladder cannot be identified ultrasonographically, when the patient has a known coagulopathy, or when the bladder wall is thickened or irregular in a way that suggests neoplasia. A veterinary radiologist should be consulted when the sonographic anatomy is ambiguous or when the procedure has failed twice under ultrasound guidance. Laboratory involvement is indicated when the drained urine is grossly abnormal, when the patient is systemically ill, or when culture and susceptibility testing is required to guide ongoing therapy. The microbiology laboratory should be informed that the sample was obtained by cystocentesis, because this affects interpretation of culture results.

Regulatory reporting is rarely required for complications of cystocentesis. If the procedure results in a serious adverse event, such as bladder rupture requiring surgical repair, the clinician should follow the reporting obligations of their jurisdiction. Professional body resources can clarify the applicable standards. International standards for animal health and welfare may apply in research or production settings, and clinicians working in those contexts should consult the relevant guidance. Imaging standards and radiation safety practices are addressed by the American College of Veterinary Radiology, and clinicians who use ultrasound should be familiar with these expectations.

Frequently Asked Questions

How should I proceed if a high-resolution ultrasound unit is unavailable?

A portable or lower-end ultrasound machine is acceptable for cystocentesis guidance. The primary requirement is real-time visualization of the bladder and needle tip, not image archival quality. Use a microconvex or sector probe if available, as these fit well between the bladder and body wall in small patients. If ultrasound is entirely unavailable, do not perform blind therapeutic drainage. Consider temporary urethral catheterization for decompression, then refer for ultrasound-guided drainage if repeated drainage is anticipated. Document the equipment limitation in the medical record and note that image quality may have affected needle tip visualization.

What is the role of therapeutic drainage in managing suspected urolithiasis or urethral obstruction?

Therapeutic drainage is not a substitute for relieving urethral obstruction. In a patient with confirmed or suspected urethral obstruction, cystocentesis can provide temporary decompression to stabilize the patient before urethral catheterization or surgery. Drainage reduces intraluminal pressure and may facilitate catheter passage by reducing bladder wall tension. Do not attempt therapeutic drainage when bladder rupture is suspected, as this risks converting a contained leak into generalized uroperitoneum. After drainage, pursue definitive management of the obstructing urolith or plug. Submit a urine sample for culture and susceptibility testing, as multidrug-resistant uropathogens are increasingly identified in companion animals with urinary tract disease MSD Veterinary Manual professional reference.

How do I decide between repeated therapeutic cystocentesis and indwelling urinary catheterization?

Repeated cystocentesis is appropriate when the underlying cause of urine retention is transient, such as post-anesthetic bladder atony, or when the patient is a poor catheterization candidate due to urethral trauma or stricture. Indwelling catheterization is preferred when drainage will be needed for more than 24 to 48 hours, when continuous urine output monitoring is required, or when the patient is recumbent and at risk of bladder overdistension between procedures. Each cystocentesis carries a small risk of bladder wall leakage or hemorrhage. If more than two drainage procedures are anticipated within a short period, reconsider the treatment plan and consult an internal medicine or surgery specialist.

What should I tell an owner when explaining why repeated bladder drainage is recommended?

Explain that the bladder is not emptying adequately and that retained urine can cause infection, bladder wall damage, and kidney injury. Describe the procedure as a sterile needle drainage performed under ultrasound guidance, similar to the diagnostic cystocentesis they may already know, but with a larger volume removed. State that sedation is usually not required, though it may be used in anxious patients. Be honest about the risks, including a small chance of blood in the urine or leakage that resolves with rest. Clarify that this is a supportive measure while the underlying cause is addressed. Owners should understand that repeated drainage is not a cure and that further diagnostics are needed.

Are there species-specific considerations for nondomestic felids or other exotic patients?

Ultrasound-guided cystocentesis has been described as a routine health check tool in captive nondomestic felids, where it provides urine for specific gravity, protein to creatinine ratio, and sediment examination under general anesthesia ultrasound-guided cystocentesis in large felid health checks. In exotic patients, general anesthesia is usually required, and the procedure is often combined with other sample collection. Bladder wall thickness and distension vary by species, so adjust needle length and approach accordingly. For very small patients, such as rabbits or ferrets, use a 25 gauge needle and limit drainage volume to avoid rapid decompression. Consult species-specific references before attempting the procedure in less familiar patients.

How should I document the procedure and what information is essential for the medical record?

Record the indication for drainage, the ultrasound findings before and after the procedure, the volume of urine removed, urine appearance and color, and any complications. Note the needle gauge and length, the number of attempts, and whether sedation was used. Include a description of the ultrasound-guided approach, such as the probe position and needle visualization quality. Document the urine specific gravity and whether samples were submitted for culture, cytology, or other testing. If the procedure was performed by a trainee, note the supervising clinician. This documentation supports continuity of care and provides a basis for comparison if the procedure is repeated AVMA practice resources on medical records.

Related Clinical & Scientific Guides

References and Further Reading

Related Articles

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.